MOBILIZED PERIPHERAL BLOOD VERSUS CORD BLOOD: DISTINCT ROLE OF PRO-INFLAMMATORY CYTOKINES ON SURVIVAL, CLONOGENIC ABILITY AND MIGRATION OF CD34+ CELLS

Inflammation may play a role in cancer. However, the contribution of cytokine-mediated crosstalk between normal hemopoietic stem/progenitor cells (HSPCs) and their (inflammatory) microenvironment is largely elusive. Here we compared survival, phenotype, and function of neonatal (umbilical cord blood (CB)) and adult (normal G-CSF-mobilized peripheral blood (mPB)) CD34(+) cells after in vitro exposure to combined crucial inflammatory factors such as interleukin- (IL-) 1 beta, IL-6, tumor necrosis factor- (TNF-) alpha, or tissue inhibitor of metalloproteinases-1 (TIMP-1). To mimic bone marrow (BM) niche, coculture experiments with normal BM stromal cells (BMSCs) were also performed. We found that combined inflammatory cytokines increased only the in vitro survival of CB-derived CD34(+) cells by reducing apoptosis. Conversely, selected combinations of inflammatory cytokines (IL-1 beta+ TNF-alpha, IL-6 + TNF-alpha, and IL-1 beta+ TNF-alpha + TIMP-1) mainly enhanced the in vitro CXCR4-driven migration of mPB-derived CD34(+) cells. TNF-alpha, alone or in combination, upregulated CD44 and CD13 expression in both sources. Finally, BMSCs alone increased survival/migration of CB- and mPB-derived CD34(+) cells at the same extent of the combined inflammatory cytokines; importantly, their copresence did not show additive/synergistic effect. Taken together, these data indicate that combined proinflammatory stimuli promote distinct in vitro functional activation of neonatal or adult normal HSPCs.